Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to help prevent the cancer from returning. The medication is designed to block the enzyme aromatase, which is responsible for converting androgens into estrogen. This reduction in estrogen can inhibit the growth of cancer cells that rely on this hormone for proliferation.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users might experience mood changes or weakness. These effects can vary in intensity and duration among individuals.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. Regular monitoring may be recommended to assess bone health and liver function. It is important to follow the advice of a healthcare provider regarding the use of this medication.

Femara may interact with certain medications, including estrogen-containing therapies and some types of antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.